These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 21053608)

  • 1. Antibody anti-p16(INK4a) in cervical cytology.
    Kane S; Ajit D; Gavas S
    Acta Cytol; 2010; 54(5 Suppl):1071-2; author reply 1072-3. PubMed ID: 21053608
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of p16INK4a and ProEx C immunostaining on cervical ThinPrep cytology and biopsy specimens.
    Oberg TN; Kipp BR; Vrana JA; Bartholet MK; Fales CJ; Garcia R; McDonald AN; Rosas BL; Henry MR; Clayton AC
    Diagn Cytopathol; 2010 Aug; 38(8):564-72. PubMed ID: 19937941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of combining testing for p16 protein and human papillomavirus (HPV) in cervical carcinoma screening.
    Ekalaksananan T; Pientong C; Sriamporn S; Kongyingyoes B; Pengsa P; Kleebkaow P; Kritpetcharat O; Parkin DM
    Gynecol Oncol; 2006 Oct; 103(1):62-6. PubMed ID: 16494930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Extend screening for cervical cancer! Improved diagnosis with papillomavirus test and colposcopy].
    Rubinstein E
    Lakartidningen; 1996 Jan; 93(5):365-6, 369. PubMed ID: 8628068
    [No Abstract]   [Full Text] [Related]  

  • 5. [Evaluation of level of expression of p16 (INK4a) in endocervical lesions of uterine cervix].
    Popovska S; Betova T; Tomov S; Gorchev G; Dikov T
    Akush Ginekol (Sofiia); 2005; 44(5):9-13. PubMed ID: 16313047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of p16INK4A in liquid-based specimens (SurePath) as marker of cervical dysplasia and neoplasia.
    Saqi A; Pasha TL; McGrath CM; Yu GH; Zhang P; Gupta P
    Diagn Cytopathol; 2002 Dec; 27(6):365-70. PubMed ID: 12451568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of liquid-based cytology specimens for the immunocytochemical study of p16 expression and human papillomavirus testing: a comparative study using simultaneously sampled histology materials.
    Yoshida T; Fukuda T; Sano T; Kanuma T; Owada N; Nakajima T
    Cancer; 2004 Apr; 102(2):100-8. PubMed ID: 15098254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between p14(ARF)/p16(INK4A) expression and HPV infection in uterine cervical cancer.
    Kanao H; Enomoto T; Ueda Y; Fujita M; Nakashima R; Ueno Y; Miyatake T; Yoshizaki T; Buzard GS; Kimura T; Yoshino K; Murata Y
    Cancer Lett; 2004 Sep; 213(1):31-7. PubMed ID: 15312681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of high-grade cervical dysplasia by the detection of p16INK4a in cell lysates obtained from cervical samples.
    Wentzensen N; Hampl M; Herkert M; Reichert A; Trunk MJ; Poremba C; Ridder R; von Knebel Doeberitz M
    Cancer; 2006 Nov; 107(9):2307-13. PubMed ID: 17029280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of p16INK4a in cervical lesion of premenopausal and postmenopausal women.
    Bolanca IK; Ciglar S
    Coll Antropol; 2007 Apr; 31 Suppl 2():107-11. PubMed ID: 17600938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus and cervical disease in adolescents.
    Guido R
    Clin Obstet Gynecol; 2008 Jun; 51(2):290-305. PubMed ID: 18463460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of p16INK4a as a diagnostic tool in the triage of Pap smears demonstrating atypical squamous cells of undetermined significance.
    Duncan L; Jacob S; Hubbard E
    Cancer; 2008 Feb; 114(1):34-48. PubMed ID: 18186493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interest of new biomarkers in cervical precancerous lesion management].
    Dachez R
    J Gynecol Obstet Biol Reprod (Paris); 2008 Feb; 37 Suppl 1():S152-4. PubMed ID: 18191337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The correlation between colposcopic directed biopsy, cervical cytology and cervical conization.
    Srisupundit S; Bunlungpoti S
    J Med Assoc Thai; 1979 Apr; 62(4):174-8. PubMed ID: 448242
    [No Abstract]   [Full Text] [Related]  

  • 15. Correlation between cervical cytology and biopsy in an air force colposcopy clinic.
    Smith KH; Bostrom SG; Galey WT
    J Reprod Med; 1985 Sep; 30(9):681-4. PubMed ID: 4057183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Precancerous cervical lesions during pregnancy: diagnostic and treatment].
    Selleret L; Mathevet P
    J Gynecol Obstet Biol Reprod (Paris); 2008 Feb; 37 Suppl 1():S131-8. PubMed ID: 18191339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of p16 as a marker for cervical cancer precursor lesions.
    O'Connor DM
    J Low Genit Tract Dis; 2007 Apr; 11(2):67-8. PubMed ID: 17415108
    [No Abstract]   [Full Text] [Related]  

  • 18. Humoral immune response to p16, a cyclin-dependent kinase inhibitor in human malignancies.
    Looi K; Megliorino R; Shi FD; Peng XX; Chen Y; Zhang JY
    Oncol Rep; 2006 Nov; 16(5):1105-10. PubMed ID: 17016600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. American Society of Cytopathology statement on new technologies in cervical cytology screening. June 2000.
    Anal Quant Cytol Histol; 2000 Aug; 22(4):351. PubMed ID: 10965413
    [No Abstract]   [Full Text] [Related]  

  • 20. Cytology or colposcopy.
    McIndoe WA
    Aust N Z J Obstet Gynaecol; 1968 Aug; 8(3):117-8. PubMed ID: 5249337
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.